Quick Answer
IN8BIO, INC. reported Total Assets of $32.28 million for the year ending 2025.
- IN8BIO, INC. showed an increase of +54.1% in Total Assets from 2024 to 2025.
- This data is from IN8BIO, INC.'s annual report (Form 10-K), filed with the SEC on March 12, 2026.
- XBRL data for this metric is available from 2020 to 2025 (6 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q2 2021: $17.56 million | Q3 2021: $47.13 million | Q1 2022: $36.54 million | Q2 2022: $30.99 million | Q3 2022: $38.38 million | Q1 2023: $24.68 million | Q2 2023: $29.72 million | Q3 2023: $26.21 million | Q2 2024: $22.50 million | Q3 2024: $15.97 million | Q1 2025: $19.87 million | Q2 2025: $19.37 million | Q3 2025: $16.77 million.
- Over the full 6 years of available data (2020 to 2025), IN8BIO, INC.'s Total Assets has grown by 54.4%.
- Historical annual values: Fiscal year 2025: $32.28 million | Fiscal year 2024: $20.94 million | Fiscal year 2023: $33.71 million | Fiscal year 2022: $33.04 million | Fiscal year 2021: $42.22 million | Fiscal year 2020: $20.91 million.
- Data sourced from SEC EDGAR public filings as of August 7, 2026.
Last verified: